NexgenRx (NXG) Stock Price, News & Analysis

Company Overview

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Key Stats

• Today's Range: C$0.30 to C$0.30
• 50-Day Range: C$0.28 to C$0.32
• 52-Week Range: C$0.23 to C$0.35
• Volume: 8,000 shs
• Average Volume: 31,765 shs
• Market Capitalization: C$21.28 million
• P/E Ratio: N/A
• Dividend Yield: 3.33%
• Price Target: N/A
• Consensus Rating: N/A

NXG Stock Analysis - Frequently Asked Questions

How have NXG shares performed this year?

NexgenRx's stock was trading at C$0.28 on January 1st, 2025. Since then, NXG stock has increased by 9.1% and is now trading at C$0.30.
View the best growth stocks for 2025 here.

How do I buy shares of NexgenRx?

Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of NexgenRx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NexgenRx investors own include WestJet Airlines (WJA), Vision Marine Technologies (VMAR), Hydro One (H) and Carvana (CVNA).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Healthcare Plans
• Sub-Industry: N/A
• Current Symbol: CVE:NXG
• CIK: N/A
• Web: www.nexgenrx.com
• Phone: +1-416-6953393
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$3.06 million
• Net Margins: -0.17%
• Pretax Margin: N/A
• Return on Equity: -0.31%
• Return on Assets: 0.42%

Debt

• Debt-to-Equity Ratio: 6.16
• Current Ratio: 1.08
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: C$15.34 million
• Price / Sales: 1.39
• Cash Flow: C$0.03 per share
• Price / Cash Flow: 9.64
• Book Value: C$0.09 per share
• Price / Book: 3.33

Miscellaneous

• Outstanding Shares: 70,920,000
• Free Float: N/A
• Market Cap: C$21.28 million
• Optionable: Not Optionable
• Beta: 0.29